Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Bionoid Pharma Inc. (BINP)

0.0800
+0.0020
+(2.56%)
As of April 25 at 4:00:00 PM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
Cost of Revenue
284.3550
Gross Profit
-284.3550
Operating Expense
8,790.3660
Operating Income
-9,074.7210
Net Non Operating Interest Income Expense
-17.1140
Pretax Income
-9,091.8350
Tax Provision
3.0990
Net Income Common Stockholders
-9,094.9340
Diluted NI Available to Com Stockholders
-9,094.9340
Basic EPS
-0.26
Diluted EPS
-0.26
Basic Average Shares
32,315.0880
Diluted Average Shares
32,315.0880
Total Operating Income as Reported
-9,074.7210
Total Expenses
9,074.7210
Net Income from Continuing & Discontinued Operation
-9,094.9340
Normalized Income
-9,094.9340
Interest Income
0.1000
Interest Expense
17.2140
Net Interest Income
-17.1140
EBIT
-9,074.6210
EBITDA
-9,041.6270
Reconciled Cost of Revenue
284.3550
Reconciled Depreciation
32.9940
Net Income from Continuing Operation Net Minority Interest
-9,094.9340
Normalized EBITDA
-9,041.6270
Tax Rate for Calcs
0.0004
1/15/57294 - 6/29/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers